reason report
solid result continu win
bottom line report good result adj ebitda
adj ep beat estim guidanc reiter
compani disclos two new partnership florida
medicaid win new york ipa live manag
describ pipelin broad deep reiter
visibl revenu health good
start beat break-even expect quarter manag
explain on-going comment support value-bas
system hh secretari azar administr
seema verma help creat sens urgenc improv
health outcom energ provid contempl
pursu value-bas care arrang continu
macro shift like benefit believ regulatori
uncertainti headwind much believ
market continu shift value-bas care
encourag commentari maintain op
pt stand host analyst day friday
excel result adj ep beat leerink/consensu
driven better-than-expect sg adj revenu
y/i beat leerink/consensu
includ benefit one-tim contribut relat
transit includ guid
 revenu trail model live platform
expect transform revenu beat model gross
margin improv bp y/i trail model
lower-than-expect sg cost led adj ebitda
y/ beat leerink/consensu adj ebitda
also benefit pull-forward performance-rel
arrang anticip later year total live
platform y/i trail model
howev manag disclos live platform
today live platform trail model manag
describ contract time affect point-in-tim measur
compani pare smaller revenu arrang
lower profit per member per month pmpm
quarter improv y/i
compani inform leerink partner llc research
revenu mm
ep exclud stock comp transact expens purchas account adjust
pleas refer page import disclosur price chart analyst certif
reiter guidanc provid guidanc bracket
estim total revenu still expect rang
compris servic revenu
health revenu inter-compani elimin
compar previou leerink/consensu total revenu
adj ebitda guid rang
compar previou leerink/consensu last
quarter manag guid total live grow
rate revenu suggest flat pmpm y/i total
revenu guid rang compar
previou leerink/consensu servic revenu
quarter expect rang
premium expect rang
inter-seg elimin adj ebitda expect
rang compar previou leerink/consensu
overal view guid decent post
strong quarter believ manag want set expect
live ad new york ipa win evol
disclos one largest independ practic associ
ipa new york area physician live
partnership initi focu support perform goal
ny deliveri system reform incent payment program
plan extend value-bas care area indentifi platform
use analyt impress win includ
larg number live manag comment see
substanti opportun increas number live platform
view win expans opportun evid
valu proposit reson provid market
seen trust partner help provid continu transit
partner run florida medicaid plan health
disclos partner health receiv intent award
contract florida agenc health administr ahca
region affili best assur estim
florida one largest medicaid state base ahca data
april estim enrol medicaid live
region total enrol medicaid live state
addit appar win describ two effort
process receiv award first round
appeal process well manag describ number thing
go florida develop shortli manag
disclos number live associ health
character partnership substanti revenu contributor
pipelin broad deep across key segment addit
recent win new york florida manag describ
pipelin remain broad deep on-going nextgen work
cite help gener interest provid commun
medicaid cite larg high growth market manag
describ well posit expans provid partner
sever state manag believ invest made
platform posit compani scale well across wide varieti
provid organ
tweak estim adjust estim quarter
good opinion encourag oper margin
expans quarter increas revenu estim
reflect growth strong execut marketplac reduc
ep estim slightli due higher estim maintain op
pt stand
expect rapidli escal healthcar cost acceler market shift away fee-
for-servic ff payment model toward risk-bas contract account
organ aco believ well posit capit burgeon
popul health manag orient market believ jump-start
field given develop root univers pittsburgh medic center upmc
core clinic vendor recent transit focu away meaning use toward
popul health manag see meaning growth expans at-risk live
across exist custom addit new custom win revenu
visibl begin year platform oper revenu grow
greater percent compani overal revenu mix amount recur revenu
also grow expect much growth given quarter come expans within evh
exist custom base believ busi model help give manag visibl
head given quarter consid high-growth market solid product servic
solut proven manag team rate share outperform
believ appropri methodolog valu share ev sale multipl
current trade ev/sal athn trade
ev/sal respect next month expect evol share
trade ev/sal would put stock price target
top-lin growth rate excel still fairli young compani turn ebitda
posit furthermor increment risk tie valenc health transact
recent elect brought republican power possibl repeal
could caus delay hcit purchas decis among larg idn solid recur
revenu model rapidli grow address market estim popul
health manag market somewhat new grow creat greater
greenfield opportun rel athn result rate share
relianc licens agreement upmc advisori board compani reli
licens agreement upmc advisori board compani upmc
ip agreement upmc technolog agreement advisori board ip agreement
addit upmc ip agreement termin acquir certain entiti
competitor upmc also licens use reproduc modifi access
busi plan oper model design creat advisori board compani
compani oper could risk unabl maintain agreement
addit upmc licens agreement preclud conduct busi certain
provid resel non-competit agreement advisori board limit evh
abil sell certain softwar technolog compet abco solut stand-alon
valenc transact pose risk acquir valenc health process
migrat client upmc platform valenc integr risk tie
data secur data privaci regulatori requir collect store analyz
confidenti inform must maintain secur access data patient clinic financi
data must handl regulatori privaci requir mind may need take
addit secur measur maintain complianc rule regul unauthor
access patient data could advers impact data loss corrupt on-line secur
potenti risk
shift value-bas vbc capit guarante evh servic premis
vision us continu see shift toward value-bas care reimburs
model although sever challeng possibl transit could lose
momentum earli vbc model limit downsid risk make buy-in easier
physician accept new payment model take time view
oper competit market mani new establish vendor
provid popul health value-bas care servic time expect number
market player grow health system gain expertis vbc contract may look
reduc number technolog vendor clinic vendor could becom
potenti long-term threat abl build robust popul health technolog solut
core ehr platform
million except per share amount
platform oper revenu
revenu
revenu
stock comp net tax
model
miss driven fewer live platform
driven transform rule pull forward
gm model good bp y/i improv
lower expect off-set gm miss
due lower opex
beat effici cost control
incom statement model fiscal year end decemb mm
estimate activ custom
live platform end qtr
averag live qtr
platform oper revenu
sale
revenu
sale
sale
non-gaap net incom common
